Patterns of laxative use for chronic functional constipation in Japanese children: A longitudinal descriptive study
Pediatrics International · 2025-01 · 67 (1)
DOI: 10.1111/ped.70293 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatrics International, online erschienen am 08.12.2025. Verfasst von Takenori Akaike und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Constipation, Laxatives, Practice Patterns, Physicians'. Die Arbeit nennt 39 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
To characterize real‐world pharmacotherapy patterns among Japanese children with chronic functional constipation (CFC), with particular attention to changes after the market introduction of polyethylene glycol (PEG) 4000 in 2019.
Methods
This longitudinal descriptive study was conducted using a Japanese health insurance claims database. We identified children aged 0–14 years who had an outpatient claim with a constipation diagnosis and received an initial prescription for laxatives lasting ≥5 days at the same visit between 2012 and 2022. We described baseline characteristics and laxative treatment trajectories throughout a 12‐month follow‐up. Subgroup analyses were performed by sex, age, and institution type.
Results
Among 166,808 eligible children, 64.1% entered the cohort after 2019. Mean age was 4.0 years and 56.6% were female. Magnesium oxide was the most commonly used laxative (31.0%), followed by PEG 4000 (19.9%). Introduction of PEG 4000 in 2019 was accompanied by a decline in prescriptions for other conventional agents. Medication choices varied by age: magnesium oxide was predominant across all age groups; PEG 4000, malt extract, and lactulose were more commonly used in younger children; and traditional Japanese Kampo medicine was favored in older children.
Conclusions
Magnesium oxide remains the most frequently prescribed laxative for pediatric CFC in Japan, with PEG 4000 now ranking second. The introduction of PEG 4000 in 2019 reduced reliance on other conventional laxatives. These findings may help clinicians tailor pharmacotherapy for childhood constipation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.
- Japan Oncology Clinical Sciences Development, Oncology Therapeutic Area Unit, Takeda Pharmaceutical Company Limited, Osaka, Japan.
- Department of Gastroenterology and Hepatology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
ORCID-Profile: Takenori Akaike, Toshiki Fukasawa, Takanori Yanai, Munenori Honda, Koji Kawakami
Zitieren
APA
Akaike, T., Fukasawa, T., Yanai, T., Honda, M., & Kawakami, K. (2025). Patterns of laxative use for chronic functional constipation in Japanese children: A longitudinal descriptive study. Pediatrics International, 67(1). https://doi.org/10.1111/ped.70293
Vancouver
Akaike T, Fukasawa T, Yanai T, Honda M, Kawakami K. Patterns of laxative use for chronic functional constipation in Japanese children: A longitudinal descriptive study. Pediatrics International. 2025;67(1). doi:10.1111/ped.70293
BibTeX
@article{Akaike2025,
author = {Akaike, Takenori and Fukasawa, Toshiki and Yanai, Takanori and Honda, Munenori and Kawakami, Koji},
title = {Patterns of laxative use for chronic functional constipation in Japanese children: A longitudinal descriptive study},
journal = {Pediatrics International},
year = {2025},
volume = {67},
number = {1},
doi = {10.1111/ped.70293}
}
EUVIMED